Publication | Closed Access
Synthesis of (<i>R</i>)-4-Oxo-5-phosphononorvaline, an<i>N</i>-Methyl-D-aspartic Acid Receptor Selective β-Keto Phosphonate
27
Citations
0
References
1994
Year
Overall YieldBiochemistryMedicineMechanism Of ActionPharmacologyPharmaceutical ChemistrySynthetic ChemistryDrug Discovery-Aspartic Acid
(R)-4-Oxo-5-phosphononorvaline (1), a selective NMDA glutamate site antagonist, has been synthesized in four steps (overall yield = 31%) from (R)-aspartic acid, without racemization.